HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognosis after percutaneous coronary intervention in patients with psoriasis: a cohort study using Danish nationwide registries.

AbstractBACKGROUND:
Psoriasis is an inflammatory disease associated with increased risk of coronary artery disease. However, the potential impact of psoriasis on the prognosis following percutaneous coronary revascularization (PCI) is unknown.
METHODS:
The study comprised the entire Danish population undergoing first-time PCI in the period 2002-09. Cox regression models, controlling for age, gender, socioeconomic status, pharmacological treatment, and comorbidity were used to assess the risk of 1) all-cause mortality and 2) a composite endpoint of death, myocardial infarction, and stroke.
RESULTS:
A total of 53,141 patients with first-time PCI in the study period were identified. Of these, 1074 had mild psoriasis and 315 had severe psoriasis. Patients with severe psoriasis, but not those with mild disease had increased risk of both endpoints compared to patients without psoriasis. The incidence rates for all-cause mortality were 30.5 (CI 29.7-31.3), 29.9 (CI 24.7-36.1), and 47.2 (CI 35.0-63.6) per 1000 patient years for patients without psoriasis, with mild psoriasis, and with severe psoriasis, respectively. Hazard ratios were 1.10 (CI 0.91-1.33) and 1.67 (CI 1.24-2.26) for mild and severe psoriasis, respectively. Patients with severe psoriasis were less likely to receive secondary prevention pharmacotherapy with betablockers, statins and platelet inhibitors.
CONCLUSION:
This first study of the prognosis following PCI in patients with psoriasis demonstrated an increased risk of all-cause mortality and of a composite of death, myocardial infarction and stroke, respectively, in patients with severe psoriasis compared to patients without psoriasis. Further studies of this novel association are needed.
AuthorsOle Ahlehoff, Jesper Lindhardsen, Gunnar H Gislason, Jonas B Olesen, Mette Charlot, Lone Skov, Christian Torp-Pedersen, Peter R Hansen
JournalBMC cardiovascular disorders (BMC Cardiovasc Disord) Vol. 12 Pg. 79 (Sep 24 2012) ISSN: 1471-2261 [Electronic] England
PMID23006590 (Publication Type: Journal Article)
Topics
  • Aged
  • Cohort Studies
  • Denmark (epidemiology)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention (adverse effects, mortality)
  • Prognosis
  • Proportional Hazards Models
  • Psoriasis (complications)
  • Registries

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: